Company Name: |
J & K SCIENTIFIC LTD.
|
Tel: |
010-82848833 400-666-7788 |
Email: |
jkinfo@jkchemical.com |
Products Intro: |
Product Name:Oxcarbazepine-D4 (Major) CAS:1020719-71-4 Package:2.5Mg,25Mg
|
Company Name: |
Clearsynth Labs Limited
|
Tel: |
+91-22-26355700 |
Email: |
info@clearsynth.com |
Products Intro: |
Product Name:Oxcarbazepine-D4 CAS:1020719-71-4 Remarks:CS-O-01318
|
Oxcarbazepine-D4 (Major) manufacturers
- Oxcarbazapine-D4
-
- $0.00 / 5mg
-
2023-05-27
- CAS:1020719-71-4
- Min. Order: 1mg
- Purity: 96%
- Supply Ability: 50 mg
|
| Oxcarbazepine-D4 (Major) Basic information |
Product Name: | Oxcarbazepine-D4 (Major) | Synonyms: | 10,11-Dihdyro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide-D4, Trileptal-D4;Oxcarbazepine-D4 (Major);Aurene-d4;GP 47680-d4;Oxecarb-d4;Oxetol-d4;10,11-Dihdyro-10-oxo-5H-dibenz[b,f]azepine-5-carboxaMide-d4;10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-1,2,3,4-d4-5-carboxamide | CAS: | 1020719-71-4 | MF: | C15H12N2O2 | MW: | 252.27 | EINECS: | | Product Categories: | Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Chiral Reagents;Heterocycles;Isotope Labelled Compounds;Metabolites & Impurities | Mol File: | 1020719-71-4.mol | ![Oxcarbazepine-D4 (Major)
Structure](CAS/GIF/1020719-71-4.gif) |
| Oxcarbazepine-D4 (Major) Chemical Properties |
Melting point | >210°C (dec.) | storage temp. | -20°C Freezer | solubility | Chloroform (Slightly), Methanol (Slightly, Heated) | form | Solid | color | White to Pale Orange |
| Oxcarbazepine-D4 (Major) Usage And Synthesis |
Chemical Properties | Pale Yellow to Pale Orange Solid | Uses | The keto derivative of Carbamazepine.
Only available as a mixture of deuterated material:
d-1: 1%
d-2: 9%
d-3: 35%
d-4: 55 | Uses | A labelled metabolite of Eslicarbazepine acetate, (BIA 2-093), a novel central nervous system drug. A keto derivative of Carbamazepine. Used as an anticonvulsant.Only available as a mixture of deuterated material:d-1: 1%d-2: 9%d-3: 35%d-4: 55% |
| Oxcarbazepine-D4 (Major) Preparation Products And Raw materials |
|